Introduction
GJs are involved. 3 Before being incorporated into GJs, unapposed/nonjunctional Cx-hemichannels reside in the plasma membrane in a closed state. Accumulating evidence suggests that hemichannels can be opened by various messengers and conditions, thereby providing a conduit that allows the passage of ions and molecules with MW up to 1.5 kDa. Hemichannels are permeable to Ca 2þ and may thus contribute to cellular Ca 2þ entry 4 and diffusive ATP release. 5 Moreover, hemichannel opening is [Ca 2þ ] i -dependent in a bimodal manner, [6] [7] [8] [9] [10] -dependence of inositol-trisphosphate receptor (IP 3 R) channels, which are Ca 2þ release channels in the endoplasmic reticulum (ER)
that play a central role in generating Ca 2þ oscillations in diverse cell types including SMCs. [11] [12] [13] Based on this similarity, we hypothesized that Cxhemichannels may contribute to Ca 2þ oscillations. Others have suggested ATP release/purinergic signalling may play a role in supporting Ca 2þ oscillations. 14 In blood-brain barrier endothelial cells, inhibiting hemichannels or ATP signalling blocked bradykinin-triggered Ca 2þ oscillations and prevented vascular barrier dysfunction. 15, 16 Vascular cells express several Cxs, including Cx37, Cx40, and Cx43 in endothelial cells, and Cx37, Cx43, and Cx45 in SMCs. [17] [18] [19] Pannexins are related to the Cx-protein family: they have a similar topology but no sequence homology with Cxs and form plasma membrane channels that, like Cx-hemichannels, are Ca 2þ -permeable and function as ATP release channels. 20, 21 Panx1 is expressed in SMCs of resistance arteries in several vascular beds 22 and plays a role in the vasoconstriction induced by a1-adrenergic stimulation of thoracodorsal arteries. 23 , 24 Here we aimed to investigate whether Cx-hemichannels are involved in SMC Ca 2þ oscillations and control of vascular tone. We used acutely isolated rat small mesenteric arteries (SMAs) exposed to the vasoconstricting agent norepinephrine and applied various tools to interfere with Cxhemichannel function and purinergic signalling. Besides gap27 peptide that inhibits hemichannels and with some latency also GJs, we applied two peptides that target intracellular Cx43 domains: L2 and CT9 (see Supplementary material online, Figure S1 ). L2 is identical to a sequence on the cytoplasmic loop (CL) of Cx43 and is known to counteract acidosis-induced GJ closure, by preventing C-terminal tail (CT) interactions with the CL (loop-tail interaction) according to a particle-receptor model. 25, 26 In contrast to this, L2 inhibits Cx43-hemichannels as con- 
Methods

Preparation of rat SMAs
SMAs (diameter $300 mm) from female Wistar rats (180-280 g) were acutely dissected and used for experiments described below. The experimental work was approved by the ethics committee on animal research of Ghent University and conformed to directive 2010/63/EU of the European Parliament. The animals were anaesthetized by a lethal dose (200 mg/kg) of pentobarbitone and killed by cervical dislocation.
Polymerase chain reaction
RNA from SMA SMCs was isolated using RNeasy Plus mini kit (Qiagen). Prior to RNA isolation, the endothelium was removed by bubbling the lumen of the vessels for 2 min with a 95% O 2 /5% CO 2 gas mixture. Reverse transcription was performed by iScript cDNA synthesis kit (BioRad) and cDNA was amplified using Taq DNA polymerase kit (Invitrogen, Merelbeke, Belgium). The PCR end products were separated on a 2% agarose gel and visualized with ethidium bromide (Invitrogen). Primer sequences and protocol see Supplementary material online.
Immunocyto-and histochemistry
Immunohistochemistry ( Figure 1B ) was done on paraffin slices with antibodies against Cx43, Cx37, and Panx1. For immunocytochemistry of Figure 1E , SMCs were isolated as described in the Supplementary mate rial online; specifics on antibodies and protocol details are given there.
Western blot analysis
For detection of Panx1 protein ( Figure 1C ), isolated SMCs were lysed and further treated as described in the Supplementary material online. The antibody used here was polyclonal rabbit anti-Panx1 antibody (Invitrogen).
Cx43 expression in tamoxifen treated Cx43
Cre-ER(T)/fl and Cx43 fl/fl mice ( Figure 6A ) were analysed using mouse cardiac tissue lysates. For antibodies and further protocol details see Supplementary material online.
Fluorescence recovery after photobleaching
SMC isolation was as for immunocytochemistry and was followed by gentle trituration with a wide-bore Pasteur pipette to obtain small cell groups, including cells pairs or cell triplets. Cells were then loaded with 5-CFDA-AM (10 mM) in Hank's balanced salt solution modified with 25 mM HEPES (HBSS-HEPES) for 1 h at room temperature, followed by 30 min de-esterification. Photobleaching and imaging was done on a confocal microscope and involved photobleaching of a single cell by spot 
Ca 2þ imaging
Artery segments were cannulated with a thin glass capillary ($15% larger than the vessel lumen diameter) with flame-polished tip, inserted into the lumen over the entire segment length of 3-5 mm. The procedure removed most of the endothelium since endothelial cells, loaded with the fluorescent Ca 2þ indicator fluo-3, were not observed while they were clearly present in non-cannulated vessels. The internal elastic lamina was observed in $50% of the cannulated preparations. Ca 2þ imaging was done on a confocal microscope with a Â40 1.3 NA oil immersion objective, at room temperature. Cannulated arterial segments were loaded with 20 mM fluo-3-AM by incubation for 2 h at room temperature in HBSS-HEPES with 0.05% pluronic. Imaging was done with the vessel segment covered by a fine nylon mesh attached to a ring and under continuous superfusion with HBSS-HEPES at a rate of 1 mL/min. Preparations demonstrating spontaneous spiking activity over a 5 min period preceding 
Electrophysiological recordings
Whole-cell recordings of Cx43 hemichannel unitary currents were performed in HeLa cells overexpressing Cx43 as previously reported. 6, 27 Charge transfer Q m was quantified by integrating unitary current activity over the duration of the applied voltage step. For detailed description see Supplementary material online.
SMA ATP release
ATP release from pieces of endothelium-denuded SMAs (3-5 mm long) was measured with an ATP bioluminescent luciferin/luciferase assay kit (Sigma, Diegem, Belgium) in combination with a luminometer plate reader (Victor3 1420 multi label counter; Perkin-Elmer, Zaventem, Belgium). ATP release was quantified relative to the total amount of releasable ATP, measured by placing the blood vessel pieces in lysis buffer (Somatic cell ATP releasing reagent, Sigma, Diegem, Belgium). ATP release was expressed relative to the 100% control value determined in each individual experiment.
Tension measurements
SMA segments (average diameter 311 6 13 mm, n ¼ 86) were mounted in an organ bath of a small-vessel myograph, filled with 10 mL Krebs Ringer Bicarbonate (KRB) solution for isometric tension measurements ( Figure 5M) . A first set of experiments was done at room temperature with the endothelium removed by gas bubbling as described above. In a second set of experiments, the endothelium was left intact and the organ bath was heated to 37 C. Only blood vessels that reacted with more than 80% relaxation to acetylcholine (10 mM) after pre-contraction with norepinephrine (3 mM) were used for experiments. Control experiments showed that vehicle solutions had no effect on contractility.
Conditional Cx43 KO animal experiments
We used Cx43 Cre-ER(T)/fl mice for Cx43 KO studies, with Cx43 fl/fl mice as controls, as previously described. 28 Cx43
Cre-ER(T)/fl mice have one allele replaced by Cre-ER(T) while the other allele is flanked by loxP recognition sites. They develop normally as Cx43 heterozygous animals while the remaining floxed Cx43 allele is excised upon 4-hydroxytamoxifen (tamoxifen) treatment. 29 Tamoxifen treatment was given to both
Cx43
Cre-ER(T)/fl and Cx43 fl/fl control animals and was ip injected at a dose of 1 mg in 100 mL sunflower oil and applied for five consecutive days; animals were sacrificed and used for experiments on Day 6 after the end of tamoxifen treatment. Animal weight was in the 27-28 g range.
Solutions
Compositions of phosphate-buffered saline (PBSD), HBSS-HEPES, and KRB solutions are given in the Supplementary material online.
Pharmacological agents
See Supplementary material online.
Statistics
Results are expressed as means 6 SEM. P-values <0.05 were considered as statistically significant. Comparison of two experimental groups was done with a Student t-test with a two-tailed P-value. Multiple groups were compared with ANOVA and a Bonferroni post-test.
Results
Connexin expression in rat SMAs
PCR analysis demonstrated Cx37 and Cx43 signals in endotheliumdenuded rat SMAs ( Figure 1A ). Immunohistochemistry on SMA sections and isolated SMCs confirmed the presence of Cx43 and Cx37 ( Figure 1B and E). We found no evidence for Panx1, not at the mRNA level ( Figure 1A) , not with immunohistochemistry ( Figure 1B) and not with western blot analysis of endothelium-denuded SMAs ( Figure 1C ). Figure S2 ). Ca 2þ oscillations induced by norepinephrine were recorded over an 11 min time-window and during this period, the Ca 2þ spike frequency and amplitude decreased spontaneously ( Figure 2A) , resulting from receptor desensitization as reported by others. 30, 31 The Ca 2þ oscillation frequency attained 2.
Norepinephrine triggers repetitive
51 6 0.44 spikes/min measured over the last 3 min of norepinephrine exposure (n ¼ 8, P < 0.001 compared with control without norepinephrine, in which case the frequency was zero). We did not find any significant effect of the various treatments with pharmacological agents discussed below, on the amplitude of the Ca 2þ spikes measured over the last 3 min period (see Supplementary material online, Figure S3 ). In the experiments that follow, we further investigated the effect of these treatments on the spiking frequency. 11 Xestospongin C (10 mM), a membrane-permeable IP 3 R inhibitor, drastically reduced the spiking activity in SMCs (see trace Figure 2B ), lowering the oscillation frequency to 0.06 6 0.03 spikes/min (n ¼ 8) measured over the last 3 min. Dantrolene (25 mM) that inhibits ryanodine receptors did not influence the oscillation frequency ( Figure 2C ). Figure 2P summarizes the effect of the compounds with the frequency normalized to the norepinephrine control frequency and significances indicated.
Norepinephrine-triggered
Interfering with connexin channels inhibits norepinephrine-induced Ca 2þ oscillations
We tested several Cx-targeting substances to determine whether these could influence norepinephrine-induced SMC Ca 2þ oscillations. The non-selective Cx-channel blocker carbenoxolone (50 mM) reduced the oscillation frequency to 0.02 6 0.02 spikes/min (n ¼ 4) ( Figure 2D and P). Gap27-peptide (200 mM) reduced the Ca 2þ oscillation frequency to 0.05 6 0.03 spikes/min (n ¼ 6) while scrambled gap27 (gap27 scr ) had no effect ( Figure 2E , F, and P). Control experiments on isolated SMC-pairs Figure S1 ) prevents CL-CT loop-tail interactions, thereby inhibiting hemichannel ATP release 10, 32 while slightly favouring the GJ open state. 33 We characterized L2 effects on hemichannel unitary currents recorded in HeLa cells exogenously expressing Cx43 with whole-cell patch clamp ( Figure 3A) . Figure 3C) . With L2 (100 mM) present in the pipette solution, Ca 2þ -promoted unitary currents were efficiently suppressed ( Figure 3C , traces and 3D, conductance histograms). Figure 3E and F summarize average data of unitary current charge transfer (Q m ) through Cx43-hemichannels. Figure 3E and F).
We tested L2 and CT9 on norepinephrine-triggered Ca 2þ oscillations in SMCs of cannulated SMAs. We applied peptides covalently linked to the TAT sequence to facilitate their plasma membrane permeation. TAT-L2 and TAT-CT9 (both 100 mM) reduced the Ca 2þ oscillation frequency to 0.87 6 0.27 spikes/min (n ¼ 7) and 0.69 6 0.22 spikes/min, respectively (n ¼ 5) ( Figure 2G , I, and P). In contrast, mutant TAT-L2 (TAT-L2 H126K/I130N
) and reversed sequence TAT-CT9 (TAT-CT9 rev ) had no effect ( Figure 2H , J, and P). TAT-CT9 inhibited the Ca 2þ oscillations but also tended to increase baseline [Ca 2þ ] i at the end of the 8 min exposure ( Figure 2I ), which is expected because CT9 facilitates hemichannel opening. We further analysed baseline fluo-3 fluorescence over the last 4 min of the recordings (expressed relative to the fluorescence in the preceding 4 min) and found that TAT-CT9 significantly increased [Ca 2þ ] i as compared with control recordings, while TAT-CT9 rev or TAT-L2 had no effect ( Table 1) . Panx1 may be involved in a1-adrenergic receptor-mediated vasoconstriction 23 and we tested 10 Panx1 (200 mM), a Panx1 channel inhibiting peptide that mimics a sequence on the second extracellular loop of Panx1. 34 These experiments showed no significant effects on the oscillation frequency ( Figure 2K and P).
Norepinephrine triggers ATP release in endothelium-denuded SMAs and purinergic receptor antagonists and ATP degrading enzymes inhibit norepinephrinetriggered Ca 2þ oscillations
We verified ATP release from endothelium-denuded SMAs (Figure 4) . Norepinephrine (3 mM, 11 min) triggered significant ATP release that was reduced to baseline by TAT-L2 co-applied with norepinephrine. Panx1 is unlikely to contribute to ATP release given the lack of evidence for its expression and absence of functional effects of 10 Panx1 ( Figure   2P ). We further tested P2X receptors involvement. The P2X 7 and P2X 2 inhibitor oxidized ATP (oATP, 300 mM, 1 h pre-incubation) 35 did not inhibit norepinephrine-induced ATP release. It rather promoted the ATP signal in control as well as with norepinephrine ( Figure 4) , most likely as a result of inhibition of ectoATPase activity. 36 We next tested two P2 receptor antagonists, suramin (200 mM) and PPADS (75 mM), on norepinephrine-induced Ca 2þ spiking and found they diminished the oscillation frequency to, respectively, 0.18 6 0.10, and 0.09 6 0.06 spikes/min (n ¼ 3 and 4, respectively) ( Figure 2L , M and P). We subsequently applied enzymes known to degrade ATP: apyrase-V (5 U/mL) degrades ATP into ADP and apyrase-VI (5 U/mL) further degrades ADP to AMP. With both enzymes present, the oscillation frequency was reduced to 0.50 6 0.19 spikes/min (n ¼ 5) ( Figure 2N and P).
Computational modelling studies of hemichannel effects on Ca 2þ oscillations
Supplementary material online, Figure S5 by TAT-L2. Norepinephrine (nor, 3 lM, 11 min) triggered significant ATP release while no significant release was observed when norepinephrine was co-applied with TAT-L2. The P2X 7 /P2X 2 inhibitor oxidized ATP (oATP, 300 lM, 1 h pre-incubation) promoted rather than inhibited ATP release. Numbers as indicated by the number of scatter dots; each dot represents an ATP measurement performed in five SMAs per well expressed relative to the baseline signal without norepinephrine (SMAs from three different animals In a first series of experiments, measurements were performed on endothelium-denuded SMAs at room temperature to resemble the conditions for recording Ca 2þ dynamics. Figure 5A illustrates a control tension measurement with contraction induced by norepinephrine (3 mM).
Pre-incubation with carbenoxolone (50 mM, 20 min) inhibited the norepinephrine-induced contractions ( Figure 5A ), reducing the area under the curve (AUC) of the trace to $56% of control ( Figure 5N ). The peak force and average force over the last 3 min of norepinephrine exposure were affected similarly and decreased to $60% and $53%, respectively. Gap27 (200 mM, 20 min) and TAT-L2 (100 mM, 20 min) inhibited contractility ( Figure 5B and C) and decreased the AUC to $74% and $50%, respectively, of control ( Figure 5N) . Surprisingly, TAT-CT9 had no effect on contractility while it inhibited Ca 2þ oscillations ( Figure 5D ). Figure 5K and L), reducing the AUC to 30% and 67%, respectively, of control ( Figure 5N) . In a second series of experiments, we performed tension measurements on endothelium-intact blood vessels at 37 C. Here, carbenoxolone, gap27, TAT-L2, suramin, and PPADS again significantly inhibited the norepinephrine-induced contractions ( Figure 5G-L) . The effects were comparable to the findings at room temperature/without endothelium and none of the AUC values, except for TAT-L2, were significantly different ( Figure 5N) . Interestingly, TAT-L2 had a significantly stronger effect at 37 C/intact endothelium as compared with room temperature/no endothelium, reducing the AUC to $20% of control ( Figure 5I and N) . Separate analysis of those cases where occasional vasomotion occurred (excluded in the analysis of Figure 5 ) demonstrated that TAT-L2 reduced the AUC to 18.7 6 6.4% of control (n ¼ 4), similar to its effect without vasomotion.
To verify whether TAT-L2 inhibition of contraction was dependent on Cx43, we performed tension measurements at 37 C on endothelium-intact SMAs isolated from tamoxifen-inducible Cx43 KO (Cx43
Cre-ER(T)/fl ) mice and corresponding Cx43 fl/fl controls. Western blot analysis of cardiac samples from tamoxifen-treated Cx43
Cre-ER(T)/fl animals demonstrated that Cx43 expression was $31% of the expression in tamoxifen-treated Cx43 fl/fl control animals ( Figure 6A and B).
Norepinephrine-induced contractions appeared smaller in tamoxifentreated Cx43
Cre-ER(T)/fl animals as compared to Cx43 fl/fl controls ( Figure 6C and D) but the difference did not attain statistical significance ( Figure 6E) . It is important to note here that Cx43 knockdown decreases both GJ and hemichannel function, which may result in effects different from hemichannel-block alone. We therefore next tested specific hemichannel block with TAT-L2 in these two animal groups. TAT-L2 inhibited the contractions in tamoxifen-treated Cx43 fl/ fl animals by $50% while inhibition was $29% in tamoxifen-treated Cx43 Cre-ER(T)/fl KO animals ( Figure 6F) . Thus, TAT-L2-inhibition of contractility was significantly reduced by $40% upon Cx43 knockdown ( Figure 6G ).
Discussion
These experiments demonstrate prominent reduction of norepinephrine-triggered blood vessel contractility by TAT-L2 that is dependent on Cx43 expression and results from hemichannel inhibition. because of its hemichannel-promotive effect, it also increased baseline [Ca 2þ ] i . TAT-CT9 had no effect on norepinephrine-induced vasoconstriction, suggesting that the increased baseline Ca 2þ signal may compensate for the reduced spiking activity in driving SMC contraction. Carbenoxolone and gap27 also inhibited Ca 2þ spiking and SMC contraction. Carbenoxolone inhibits both hemichannels and GJ channels, while gap27 first blocks hemichannels and with some delay (variable between cell types) also GJs. 6, 15, 38 Gap27 is identical to a sequence on the extracellular loop of the Cx-protein that is well conserved between different Cxs and therefore targets multiple Cxs, for example Cx37 and Cx43 present in SMCs. In contrast, L2 is identical to a sequence on the Cx43 CL that is a non-conserved domain. Its interaction partner is the Cx43 CT, which is very different between different Cxs. As a result, L2-peptide selectively targets Cx43, as recently confirmed for L2-derived gap19-peptide that has no effect on Cx40 or Panx1 based hemichannels. 27 L2 and gap19 have in common that they slightly promote junctional coupling by decreased dwelling of GJ channels in the subconductance state. 27, 33 Gap27 has previously been demonstrated to inhibit contractility of rat aorta 39 and a combination of gap27/gap26 suppressed vasomotion in rat SMAs. 40 In these cases, the effect was attributed to inhibition of GJs, either between SMCs, endothelial cells, or as myoendothelial junctions. With the exposure times used here, gap27 did not influence GJ coupling, moreover, in recordings without endothelium, endothelial, and myoendothelial GJs are absent, while in all recordings we avoided vasomotion to limit GJ contribution. At 37 C and intact endothelium, carbenoxolone, gap27, and TAT-L2 had comparable effects on vessel contractility as recorded at room temperature/without endothelium. In contrast, TAT-L2 had a much stronger effect at 37 C/ intact endothelium. This may relate to temperature effects on channel 45 and therefore only contributes to the initial phase of the responses. Suramin and PPADS are not specific for these various P2 subtypes, but the suramin spectrum includes P2X 1 while this receptor is insensitive to PPADS. This appears to be reflected in the contractions, where suramin inhibition was more complete, while PPADS spared the initial contraction peak ( Figure 5 ). Taken together with the strong inhibition by the extracellular ATP-degrading apyrase mix, these results indicate A limitation of the present study is that the findings are not necessarily applicable to blood vessels from other perfusion areas. Additionally, the direct demonstration of Cx43 hemichannel opening in SMCs proved to be difficult, which is not unexpected given the computational prediction that the opening of just a single hemichannel is sufficient to explain the present findings. Involvement of just one hemichannel per SMC would give a peculiar, grainy pharmacological response, which was indeed observed in the effect of gap27 and TAT-L2 (but also with xestospongin). At the level of contractility such granularity is smoothed out by the contribution of multiple SMCs and thus multiple hemichannels.
We conclude that TAT-L2 strongly inhibits norepinephrine-induced SMA contraction, with Cx43 hemichannel opening and Ca 2þ /purinergic signalling as major contributing signalling events. Peptides targeting Cx43-hemichannels may thus be interesting tools to modulate vascular function.
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Supplementary material is available at Cardiovascular Research online. 
